Elekta

Related Party Transaction • Jun 15, 2009

ELEKTA SIGNS COOPERATIVE AGREEMENT WITH SWEDISH EXPORT CREDIT CORPORATION

Stockholm, June 15, 2009

The medical technology company Elekta has entered a cooperative agreement with SEK, the Swedish Export Credit Corporation. The agreement entails customer financing and applies globally with the exception of North America, where Elekta already has an established partner for customer financing.

The cooperative agreement with SEK Customer Financing strengthens and expands Elekta's opportunities for offering competitive solutions for customer financing. Within the framework of the agreement, SEK will offer care providers around the world financing in the form of installment credit and leasing of Elekta's clinical systems.

Elekta will be able to offer customers financing with limited impact on its own balance sheet.

"Since the credit crisis began, we have seen increased demand for alternative financing solutions. I am therefore delighted that we are now able to offer our customers a broad range of attractive solutions in this area," says Håkan Bergström, CFO at Elekta.

"We are pleased to be entrusted with assisting Elekta with its customer financing platform. This agreement is completely in line with our ambition to increase the competitiveness of Swedish export companies in the global market," says Peter Yngwe, President of SEK.

******

For further information, please contact:

Håkan Bergström, CFO, Elekta AB Tel: +46 8 587 25 520, e-mail: hakan.bergstrom@elekta.com

Stina Thorman, Investor Relations, Elekta AB Tel: +46 8 587 25 437, e-mail: stina.thorman@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.